Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
18.86
-0.40 (-2.08%)
At close: Jan 16, 2026, 4:00 PM EST
19.39
+0.53 (2.81%)
After-hours: Jan 16, 2026, 7:19 PM EST
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $574.59 million as of January 16, 2026. Its market cap has decreased by -10.39% in one year.
Market Cap
574.59M
Enterprise Value
-101.45M
1-Year Change
-10.39%
Ranking
Category
Stock Price
$18.86
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $574.59M, an increase of 49.12%. That is a compound annual growth rate of 7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 574.59M | -7.37% |
| Dec 31, 2025 | 620.29M | -3.27% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |